- Title
- TP003/#1538 Phase 3 ENGOT-en23/GOG-3095/MK-2870–005 study: sacituzumab tirumotecan (Sac-TMT) monotherapy vs treatment of physician’s choice chemotherapy in patients with endometrial cancer who received prior chemotherapy and immunotherapy
- Creators
- Domenica LorussoToon Van Gorp - ENGOT-BGOG and Division of Gynaecological Oncology, University Hospital Leuven and KU Leuven, Leuven Cancer Institute, Leuven, BelgiumFlora Zagouri - Alexandra HospitalLubomir Bodnar - ENGOT-PGOG and Department of Clinical Oncology and Radiotherapy, Mazovia Regional Hospital, Siedlce Oncology Center, Siedlce, PolandDearbhaile Collins - Cork University HospitalJacob Korach - Sheba Medical CenterChristian Marth - AGO AustriaJudith Kroep - ENGOT-DGOG and Leids Universitair Medisch Centrum, Leiden, NetherlandsJianqing Zhu - Department of Gynecologic Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, ChinaKosei Hasegawa - Saitama Medical UniversityVanessa Samouëlian - Centre Hospitalier de l’Université de MontréalJung-Yun Lee - Severance HospitalFernanda Casarotto - Hospital Moinhos de VentoYoland Antill - Universitat de Vic - Universitat Central de CatalunyaDana Chase - University of California, Los AngelesMark Shahin - Doylestown HospitalRobert Orlowski - Merck and Co., Inc., Rahway, USAKristina Woodhouse - Merck and Co., Inc., Rahway, USAYi Cui - Merck and Co., Inc., Rahway, USALyndsay Willmott - HonorHealthBradley Monk - GOG and Florida Cancer Specialists and Research Institute, West Palm Beach, USA
- Publication Details
- International journal of gynecological cancer, Vol.34, pp.A348-A348
- Publisher
- Elsevier Inc
- Identifiers
- 991006133536802656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
TP003/#1538 Phase 3 ENGOT-en23/GOG-3095/MK-2870–005 study: sacituzumab tirumotecan (Sac-TMT) monotherapy vs treatment of physician’s choice chemotherapy in patients with endometrial cancer who received prior chemotherapy and immunotherapy
International journal of gynecological cancer, Vol.34, pp.A348-A348
10/2024
Metrics
1 Record Views